Check out the companies making headlines before the bell. ARCELUX — Biotech stocks soared 78% after Gilead Sciences announced Monday that it has agreed to acquire Arcelx for $7.8 billion, offering $115 in cash per share and a contingent value right of $5 per share at closing. Arcellx focuses on immunotherapy for patients with cancer and other difficult diseases. The transaction is expected to close in the second quarter. Novo Nordisk , Eli Lilly — Novo Nordisk fell 14% after its weight-loss drug Kaglisema failed to compete with Eli Lilly’s drug in a recent trial. Eli Lilly shares rose nearly 3%. Domino’s Pizza — The pizza chain rose 4% after fourth-quarter U.S. sales rose 3.7%, beating the FactSet consensus estimate of 3.1%. Overall revenue for the fourth quarter also exceeded expectations, coming in at $1.54 billion versus expectations of $1.52 billion. Fortune Brands Innovations — Shares rose 4% after the Wall Street Journal reported that investor Ed Garden has acquired a stake in Fortune Brands and is seeking to replace the company’s next CEO. VF Corp — Shares fell about 3.5% after the global apparel, footwear and accessories company was downgraded by JPMorgan. Analysts said Vans’ brand recovery could take a significant amount of time, with sales at wholesalers and direct retailers likely suffering double-digit declines.
